Susan Polgar and Infectech, Inc.
On Sep 11, 5:03 pm, samsloan wrote:
While searching for information about Susan Polgar's claim to be able
to raise $2 million dollars to hold a match for the Woman's World
Championship, I found the following remarkable press release in the
archives of Susan Polgar's old website athttp://web.archive.org/web/20010515233158/http://polgarchess.com/
Among the many remarkable things about this press release is it claims
to have products for the faster detection of Tuberculosis and many
other diseases, but fails to explain why it would seek the help of
Susan Polgar in marketing these products.
Apparently, nothing came of this. The match of course never took
place. By the time of this press release, Polgar's world championship
title had already been declared forfeited and Xie Jun was the new
world champion. This press release may explain why Polgar kept
insisting that the match be postponed to September 1999 and kept
saying that she would be able to raise two million dollars for the
match by that time.
Sam Sloan
PRESS RELEASE
FOR: Infectech, Inc. and Company
CONTACT: Mitchell S. Felder, M.D. Sharon, PA
(724) 346-1302
FOR: Newcomb CONTACT: Fred Newcomb
Burlington, MA
(781) 272-6232
FOR IMMEDIATE RELEASE
October 21, 1999
Susan Polgar to Participate in Women's World Chess Championship
Co-Sponsored by Infectech, Inc.
Sharon, PA - October 21, 1999 - Infectech, Inc. (IFEC:NQB) announced
today that Susan Polgar, the Women's World Chess Champion has signed a
contract with Infectech for sponsorship of a Women's World Chess
Championship event. Under the terms of the contract, Infectech, Inc.
will seek sponsorship by a multinational corporation for a $2.3
million prize fund to be divided by the contestants. The prize fund
will consist of $1.1 million in cash and up to one million IFEC
private placement shares, having a $1.2 million value, to be purchased
by the sponsoring multinational corporation. Infectech, Inc. has
signed a Letter of Intent with Judith Polgar, the highest ranking
female chess player in world history, and the sister of Susan Polgar,
for participation in this event. Susan Polgar is a member of the
Infectech Scientific Advisory Board, and Grandmaster Susan Polgar has
agreed to represent the United States in this world championship
match.
Dr. Mitchell S. Felder, CEO and President of Infectech, Inc., stated
that, "We are quite excited to have Infectech serve as the catalyst
for this prestigious event. This event will be a truly innovative
mechanism by which IFEC can allocate $1.2 million dollars of funding
for the IFEC products involving the faster detection of Tuberculosis,
M. avium (one of the major bacterial infections of AIDS patients),
Pseudomonas (a major bacterial killer of cystic fibrosis and cancer
patients), as well as for the bioremediation of environmental
contaminants. It is a beautiful concept that a chess tournament may
assist in the further development of these most humanitarian medical
products which have the potential for saving thousands of lives."
IFEC management believes that in light of the recent Kasparov vs. The
World internet chess game, which received the most internet web hits
in history, this chess tournament could likewise serve to highlight
the innovative IFEC medical diagnostics technology and extensive
intellectual property.
The tournament hopes to have the participation of Xie Jun of China
(the recent FIDE Women's Chess Champion, which is being contested in
court by Susan Polgar), as this tournament could definitively prove
who is the best female chess player in the world. Infectech has
already been shown a great deal of initial interest by multinational
corporations in a possible co-sponsorship of this event.
Infectech, Inc., founded in 1989, is a biotechnology company which
owns 26 patents for the rapid identification and antibiotic
sensitivity testing of 34 disease-causing bacteria, including
Tuberculosis, Pseudomonas, M. avium and Nocardia. These bacteria play
a prominent role in causing the death of cancer, Cystic Fibrosis and
AIDS patients, and those undergoing surgery. The company's primary
focus is the development of a system for rapidly identifying bacteria
infecting hospital patients utilizing its patented baiting technology
in combination with fluorescent amplification. MD-Diagnostics.com,
Inc., is a subsidiary formed by Infectech, and is dedicated to medical
diagnostics over the Internet. The Infectech web site iswww.infectech.com.
The Polgar web site iswww.polgarchess.com.
The Fake Sam Sloan keeps covering up my Polgar threads so here it is
again.
|